IMMUNOANALYSIS CHIMIOLUMINISCENTE DE MICROPARTICULAS (CMIA) FOR THE QUALITATIVE DETECTION OF ANTIBODIES AGAINST THE ANTIGENOCORE OF HEPATITIS B VIRUS (ANTI HBC) HUMAN PLASMA AND PLASMA, INCLUDING POST-MORTEM RENEWED SAMPLES (WITHOUT CARDIAC TREATMENT).
It is a fully automated immunoassay system that allows random and continuous access, as well as priority processing and automatic re-analysis using chemoluminescent micro-particle immunoassay technology. CMIA technology is used to determine the presence of antigens, antibodies and analytes in samples. The scalable design of the ALINITY I allows one or more sample processing modules, in multiple configurations, with a system control module to physically join together to form a single workstation.
Reference. 8L4425 Lots: 42072LI00, 42072LI01, 42253LI00, 42253LI01, Reference.8L44-30 Lots 42255LI00, 4225LI01, Reference. 8L44-35 Lot 42256LI00
Descripción del producto
Chemiluminescent immunoanalysis of macroparticles for the qualitative detection of antibodies against the CORE antigen of Hepatitis B virus (ANTI HBC) in serum and human plasma including samples collected POSTMORTEM
Catheters for coronary dilatation are used for: 1. Balloon dilatation of the stenotic portion of a coronary artery from the stenosis of a bypass graft in order to improve myocardial perfusion. 2. Balloon dilatation of an occlusion in a coronary artery, in order to restore coronary flow in cases of myocardial infarction with ST-segment elevation. 3. Dilation with balloon of a stent after implanting it (balloon models from 2.00 mm to 5.00 mm only).